The Korean Journal of Physiology and Pharmacology

The Korean Society of Pharmacology (대한약리학회)
권호 표지

Differential Activation of Ras/Raf/MAPK Pathway between Heart and Cerebral Artery in Isoproterenol-induced Cardiac Hypertrophy

  • Kim, Hyun-Ju (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Kim, Na-Ri (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Joo, Hyun (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Youm, Jae-Boum (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Park, Won-Sun (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Warda, Mohamed (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Kang, Sung-Hyun (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Thu, Vu-Thi (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Khoa, Tran-Minh (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University) ;
  • Han, Jin (Mitochondrial Signaling Laboratory, Department of Physiology and Biophysics, College of Medicine, Cardiovascular and Metabolic Disease Center, Biohealth Products Research Center, Inje University)
  • Published : 2005.10.21
Download PDF
⟨ Previous Next ⟩

Abstract

Cardiac hypertrophy contributes an increased risk to major cerebrovascular events. However, the molecular mechanisms underlying cerebrovascular dysfunction during cardiac hypertrophy have not yet been characterized. In the present study, we examined the molecular mechanism of isoproterenol (ISO)-evoked activation of Ras/Raf/MAPK pathways as well as PKA activity in cerebral artery of rabbits, and we also studied whether the activations of these signaling pathways were altered in cerebral artery, during ISO-induced cardiac hypertrophy compared to heart itself. The results show that the mRNA level of c-fos (not c-jun and c-myc) in heart and these genes in cerebral artery were considerably increased during cardiac hypertrophy. These results that the PKA activity and activations of Ras/Raf/ERK cascade as well as c-fos expression in rabbit heart during cardiac hypertrophy were consistent with previous reports. Interestingly, however, we also showed a novel finding that the decreased PKA activity might have differential effects on Ras and Raf expression in cerebral artery during cardiac hypertrophy. In conclusion, there are differences in molecular mechanisms between heart and cerebral artery during cardiac hypertrophy when stimulated with β2 adrenoreceptor (AR), suggesting a possible mechanism underlying cerebrovascular dysfunction during cardiac hypertrophy.

Keywords

References

  1. Boluyt MO, Long X, Eschenhagen T, Mende U, Schmitz W, Crow MT, Lakatta EG. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am J Physiol Heart Circ Physiol 269: H638-H647, 1995
  2. Burgering BMT, Pronk GJ, Weeren PC, Chardin P, Bos JL. CAMP antagonizes p21 ras-directed activation of extracellular signalregulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J 12: 4211-4220, 1993
  3. Cook SJ, McCormick F. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262: 1069-1072, 1993 https://doi.org/10.1126/science.7694367
  4. D'Angelo G, Lee H, Weiner RI. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 67: 353-366, 1997 https://doi.org/10.1002/(SICI)1097-4644(19971201)67:3<353::AID-JCB7>3.0.CO;2-V
  5. Daniela G, Stephan R, Holmer, Gunter AJR, Eckhard PK. Effects of beta-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat. Cardiovasc Pathol 8: 315-323, 1999 https://doi.org/10.1016/S1054-8807(99)00021-6
  6. Faure M, Bourne HR. Differential effects of cAMP on the MAP kinase cascade: evidence for a cAMP insensitive step that can bypass Raf-1. Mol Biol Cell 6: 1025-1035, 1995
  7. Faure M, Voyno-Yasenetskaya TA, Bourne HR. cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269: 7851-7854, 1994
  8. Froedin M, Peraldi P, Obberghen E. Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269: 6207-6214, 1994
  9. Hecquet C, Lefevre G, Valtink M, Engelmann K, Mascarelli F. cAMP inhibits the proliferation of retinal pigmented epithelial cells through the inhibition of ERK1/2 in a PKA-independent manner. Oncogene 21: 6101-6112, 2002. https://doi.org/10.1038/sj.onc.1205765
  10. Liza BH, Louis M, Luttrell, Howard A, Rochman. Dual inhibition of $\beta$-adrenergic and angiotensin II receptors by a single antagonist. Circulation 108: 1611-1618, 2003 https://doi.org/10.1161/01.CIR.0000092166.30360.78
  11. Morgan HE, Baker KM. Cardiac hypertrophy. Mechanical, neural, and endocrine dependence. Circulation 83: 13-25, 1991 https://doi.org/10.1161/01.CIR.83.1.13
  12. Nagano M, Higaki J, Nakamura F, Higashimori K, Nagano N, Mikami H, Ogihara T. Role of cardiac angiotensin II in isoproterenol- induced left ventricular hypertrophy. Hypertension 19: 708-712, 1992 https://doi.org/10.1161/01.HYP.19.6.708
  13. Selvetella G, Notte A, Maffei A, Calistri V, Scamardella V, Frati G, Trimarco B, Colonnese C, Lembo G. Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients. Stroke 34: 1766-1770, 2003 https://doi.org/10.1161/01.STR.0000078310.98444.1D
  14. Toshiyuki T, Toshihisa A, Tsutomu Y, Yuichiro M, Keitaro M, Michikado I, H. Kirk H, Satoshi O. Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling. J Am Coll Cardiol 43: 125-132, 2004 https://doi.org/10.1016/j.jacc.2003.07.036
  15. VanRenterghem B, Browning MD, Maller JL. Regulation of mitogen- activated protein kinase activation by protein kinases A and C in a cell-free system. J Biol Chem 269: 24666-24672, 1994
  16. Verdecchia P, Porcellati C, Reboldi G, Gattobigio R, Borgioni C, Pearson TA, Ambrosio G. Left ventricular hypertrophy as an independent predictor of acute cerebrovascular events in essential hypertension. Circulation 10417: 2039-2044, 2001
  17. Wan Y, Huang XY. Analysis of the Gs/Mitogen-activated Protein Kinase Pathway in Mutant S49 Cells. J Biol Chem 273: 14533-14537, 1998 https://doi.org/10.1074/jbc.273.23.14533
  18. Wankerl M, Schwartz K. Calcium transport proteins in the nonfailing and failing heart: gene expression and function. J Mol Med 73: 487-496, 1995
  19. William ES, Hong X, John FR, Jean BR, Sharon A, Scott LM. Angiotensin II enhances $\beta$-adrenergic receptor-mediated vasorelaxation in aortas from young but not old rats. Am J Physiol Heart Circ Physiol 279: H2807-H2814, 2000
  20. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3',5' -cyclic monophosphate. Science 262: 1065-1069, 1993 https://doi.org/10.1126/science.7694366
  21. Yamazaki T, Komuro I, Zou Y, Kudoh S, Mizuno T, Hiroi Y, Shiojima I, Takano H, Kinugawa K, Kohmoto O, Takahashi T, Yazaki Y. Protein kinase A and protein kinase C synergistically activate the Raf-1 kinase/mitogen-activated protein kinase cascade in neonatal rat cardiomyocytes. J Mol Cell Cardiol 29: 2491-2501, 1997 https://doi.org/10.1006/jmcc.1997.0488
  22. Yao H, Labudda K, Rim C, Capodieci P, Loda M, Stork PJS. Cyclic Adenosine Monophosphate Can Convert Epidermal Growth Factor into a Differentiating Factor in Neuronal Cells. J Biol Chem 270: 20748-20753, 1995 https://doi.org/10.1074/jbc.270.35.20748
  23. Zierhut W, Zimmer HG. Significance of myocardial alpha- and betaadrenoceptors in catecholamine-induced cardiac hypertrophy. Circ Res 65: 1417-1425, 1989 https://doi.org/10.1161/01.RES.65.5.1417